Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 18 Aug 2026 for Verrica Pharmaceuticals Inc., €26k.
Filing timeline
BuySaleDavid Zawitz
Insider track record
Disclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
David Zawitz: trading record in brief
David Zawitz discloses dealings in Verrica Pharmaceuticals Inc. to SEC (Form 4). We count 2 filings; the first trade dates from 25 November 2025 and the latest from 17 August 2026.
No open-market sale appears; the market trades are 2 purchases worth €63k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2026 to date brings 1 purchase and no sales.
Most recently, on 18 August 2026, the filings show an open-market purchase worth €26k in Verrica Pharmaceuticals Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to David Zawitz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
6,000 shares@ US$4.98Common StockSEC:0002046750-26-000004:0
Canonical exit: 15 Nov 2026 (T+90)
10,000 shares@ US$4.2425100.0% of flowCommon StockSEC:0002046750-25-000004:0
Canonical exit: 23 Feb 2026 (T+90)
2 of 2 declarations
